Mangalam Organics dispatches 44th AGM notice and annual report for FY26

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Mangalam Organics schedules its 44th AGM for September 24, 2026, via video conferencing
  • Notice and FY26 annual report dispatched to members with unregistered emails as of August 21, 2026
  • Compliance with SEBI Regulation 36(1)(b) ensures electronic access via web-links and QR codes
  • Shareholders urged to update KYC details and dematerialise physical securities per recent circulars
powered bylight_fuzz_icon
49548075

*this image is generated using AI for illustrative purposes only.

Mangalam Organics Limited has dispatched the notice convening its 44th Annual General Meeting (AGM) and the Integrated Annual Report for the Financial Year 2025-26. The meeting is scheduled for Thursday, September 24, 2026, at 3:00 pm through Video Conferencing or Other Audio-Visual Means.

The communication was issued on August 29, 2026, pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically targets members whose email addresses are not registered with the company, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), or their respective Depository Participants as of the cut-off date of August 21, 2026.

Meeting Details and Access

Shareholders who have not registered their email IDs will receive a physical letter containing a web-link, exact path, and QR code to access the AGM notice and annual report electronically. This process ensures compliance with regulatory requirements while encouraging digital adoption.

Document Access Method
44th AGM Notice Electronic mail / Physical letter with web-link
Integrated Annual Report FY26 Company website / Stock exchange websites

The documents are also available on the company’s website at www.mangalamorganics.com under the Investors section. The notice was signed by Charmi Shah, Company Secretary & Compliance Officer.

KYC and Demat Updates

The dispatch serves as a reminder for security holders holding physical securities to update their KYC details and dematerialise holdings in line with SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 7, 2024. Listed companies are mandated to record PAN, address with PIN code, mobile number, bank account details, specimen signature, and choice of nomination for physical holders.

Shareholders are advised to register their email IDs to avail online services and receive important communications electronically. Formats for nomination and KYC updation (Forms ISR-1, ISR-2, ISR-3, SH-13, and SH-14) are available on the RTA website.

Historical Stock Returns for Mangalam Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+2.12%+10.92%-2.97%+23.71%-11.23%0.0%

What specific financial performance metrics and strategic initiatives are highlighted in Mangalam Organics' Integrated Annual Report for FY2025-26?

How might the upcoming AGM resolutions impact the company's dividend policy or capital allocation strategy for the next fiscal year?

What is the expected timeline for Mangalam Organics to achieve full compliance with SEBI's mandate on dematerialization of physical securities?

Mangalam Organics consolidated profit falls 41% in Q1FY27 despite revenue growth

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Mangalam Organics Limited reported a significant divergence between top-line growth and bottom-line profitability for Q1FY27. Consolidated net profit fell 41% YoY to ₹7.27 crore despite a 22% rise in revenue to ₹179.09 crore. EBITDA margins contracted to 12.40% from 14.74%, indicating margin compression. Standalone profits also declined 23% YoY to ₹5.32 crore.

powered bylight_fuzz_icon
46857652

*this image is generated using AI for illustrative purposes only.

Mangalam Organics Limited reported a sharp divergence between top-line growth and bottom-line profitability for the quarter ended June 30, 2026 (Q1FY27). Consolidated net profit after tax (PAT) declined 41% year-on-year to ₹7.27 crore from ₹12.23 crore in Q1FY26, even as revenue from operations surged 22% to ₹179.09 crore. The Board of Directors approved the unaudited financial results on July 28, 2026, following review by the Audit Committee. Statutory auditors expressed an unmodified review opinion on the financial statements.

Standalone figures also reflected profit compression, with net profit falling 23% YoY to ₹5.32 crore from ₹6.92 crore. Standalone total income rose 37% to ₹163.14 crore. The company submitted its investor presentation for the quarter and the full financial year ended March 31, 2026, to the stock exchanges on July 30, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

Metric Standalone Q1FY27 Standalone Q1FY26 Change Consolidated Q1FY27 Consolidated Q1FY26 Change
Revenue from Operations (₹ cr) 163.14 119.13 +37% 179.09 146.55 +22%
EBITDA (₹ cr) 6.38* 8.24* -23% 22.21 21.60 +3%
Net Profit After Tax (₹ cr) 5.32 6.92 -23% 7.27 12.23 -41%
EPS Basic & Diluted (₹) 6.22 8.08 -23% 8.49 14.28 -41%

*Note: Pre-tax profit figures used as proxy for EBITDA in standalone context where explicit EBITDA was not separately itemized in the summary table but derived from PBT adjustments in detailed statements.

The paid-up equity share capital remained unchanged at ₹8.56 crore. Consolidated earnings per share stood at ₹8.49, down from ₹14.28 in the previous year’s quarter.

What the Numbers Show

The primary driver of the profit decline is margin compression rather than operational volume issues. While consolidated revenue grew by 22%, consolidated EBITDA increased by only 3% to ₹22.21 crore, causing the EBITDA margin to contract from 14.74% in Q1FY26 to 12.40% in Q1FY27. This indicates that rising input costs or other operating expenses were not fully passed on to customers or offset by efficiency gains.

In the standalone segment, the disconnect is more severe: revenue surged 37%, yet pre-tax profit fell 23%. This suggests significant headwinds in the core manufacturing operations, potentially linked to higher cost of materials consumed or specific one-off charges not present in the prior year. The consolidated balance sheet as of March 2026 showed total assets of ₹740 crore against total liabilities of ₹740 crore, with borrowings increasing from ₹35 crore in March 2025 to ₹55 crore in non-current liabilities and ₹301 crore in current liabilities, indicating increased leverage to fund operations or expansion.

Historical Stock Returns for Mangalam Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+2.12%+10.92%-2.97%+23.71%-11.23%0.0%

Will Mangalam Organics implement price hikes or renegotiate supplier contracts to reverse the 2.34% contraction in consolidated EBITDA margins?

How does the sharp increase in current liabilities to ₹301 crore impact the company's liquidity position and short-term debt servicing capabilities?

Are the standalone profit declines driven by one-off charges or structural inefficiencies in core manufacturing that require capital expenditure to resolve?

More News on Mangalam Organics

1 Year Returns:-11.23%